Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-011587

SVP & Chief Scientific Officer sold 2,426 shares at $82.94 ($201,212)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2018-02-16 Sale −2,426 $82.94 $201,212 67,394 D: show line 1 in the form
Open-market sales · 2,426 sh · avg $82.94 · $201,212
Loading xslF345X03/doc4.xml…